Sectors
CHRO
Channel Therapeutics Corporation
1.35
1 x 1.29
2 x 1.38
bid
ask
+
0.09
7.14%
04:00 PM
| Ytd | ||
| 1y |
1.23
day range
1.48
1.23
52 week range
54.29
| Open | 1.25 | Prev Close | 1.26 | Low | 1.23 | High | 1.48 | Mkt Cap | 8.90M |
| Vol | 193.12K | Avg Vol | 111.31K | EPS | -12.00 | P/E | -0.11 | Forward P/E | -0.58 |
| Beta | 3.63 | Short Ratio | 0.26 | Inst. Own | 7.07% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 12.03 | 200-d Avg | 12.00 | 1yr Est | 8.50 |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2024-06-18 | Alliance Global Partners | Upgrade | Buy |
Profile
Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the development and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain and acute and chronic eye pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2024-02-20 | DAVIS TODD CLIFTON | Director | 29.17K | Conversion of Exercise of derivative security |
| 2024-09-12 | FRANCIS KNUETTEL II | Chief Executive Officer | 0.00 | Purchase |
| 2024-02-20 | FRIEDBERG EZRA M | Director | 0.00 | Conversion of Exercise of derivative security |
| 2024-09-11 | MALAMUT RICHARD | Director | 0.00 | Purchase |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Avantax Planning Partners, Inc. | 47.21K | 30.21K | 0.78% |
| 2024-09-29 | Two Sigma Securities, LLC | 26.06K | 16.68K | 0.43% |
| 2024-09-29 | Wealth Enhancement Advisory Services, LLC | 10.40K | 6.66K | 0.17% |
| 2024-09-29 | Tower Research Capital LLC (TRC) | 259.00 | 165.00 | 0.00% |
| 2024-09-29 | Bank of America Corporation | 11.00 | 7.00 | 0.00% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-10-30 | Fidelity Extended Market Index Fund | 5.01K | 3.21K | 0.08% |
Split
| Split | Date |
|---|---|
| 1 : 10 | 2025-07-02 |